AI assistant
Sending…
Axogen, Inc. — Director's Dealing 2014
Oct 10, 2014
32414_dirs_2014-10-10_41732a2a-29f8-4ae7-8444-25fa19bead97.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2014-10-08
Reporting Person: Freitag Gregory Gene (Director, CFO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-10-01 | Employee Stock Option (right to buy) | $2.46 | A | 16000 | Acquired | 2020-10-01 | common Stock (16000) | Direct |
More from Axogen, Inc.
Major Shareholding Notification
2026
May 7
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Interim / Quarterly Report
2026
Apr 28
Earnings Release
2026
Apr 28
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3